Researchers at Academia Sinica and National Taiwan University Hospital have developed an AI-powered blood test that detects early-stage pancreatic cancer with near-perfect accuracy in validation ...

Researchers at the Lawrence Berkeley National Laboratory have developed a design and training framework ...

The deal could be worth more than $1 billion, if all genetic targets identified lead to approved therapeutics.

Alnylam is broadening its position in the area of RNA interference (RNAi) gene-silencing therapies for cardiovascular diseases via a partnership with Tenaya Therapeutics, claiming rights to use the ...

What if the thermal noise that hinders the efficiency of both classical and quantum computers could, instead, be used as a ...

Overview AI medical diagnosis can recognize disease patterns even before symptoms worsenPredictive healthcare models delve into risk factors over the long termM ...

Agreement Combines Tenaya’s Expertise in Identification and Validation ofGenetic Heart Disease Targets with Alnylam’s Ability to Deliver Transformational Therapeutics Tenaya to Receive Up to $10 ...

Market Outlook and Growth TrajectoryThe global next generation sequencing market is poised to experience robust expansion, registering an estimated growth rate of around 15% over the next five years.

The DNA foundation model Evo 2 has been published in the journal Nature. Trained on the DNA of over 100,000 species across ...

Researchers from Duke Health and the University of Minnesota recently discovered that measuring specific tiny genetic ...

AI-enhanced optical spectroscopy revolutionizes food quality monitoring with rapid, non-destructive analysis, ensuring safety and reducing waste in production.